Evans John M. sold BEAM
January 30, 2026 · Form 4 insider transaction
Evans John M. sold 2,906 shares of Beam Therapeutics Inc. at $29.00 per share, a transaction worth $84.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,906
Price
$29.00
Total value
$84.3K
InsiderEvans John M.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 30, 2026
Filing dateFebruary 2, 2026
Shares owned after986,667
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.